Skip to search formSkip to main contentSkip to account menu

WR 151327

Known as: 1-Propanethiol, 3-((3-(methylamino)propyl)amino)-, dihydrogen phosphate (ester), WR-151327 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Combined injuries, which are expected after a radiation dispersal device release or nuclear weapon detonation, are the… 
2001
2001
The effect of combining a radiation‐protective phosphorothioate with another agent was investigated in an attempt to increase… 
2000
2000
PURPOSE To determine the efficacy of WR-151327 (WR) [S-3-(3-methylaminopropylamino) propylphosphorothioic acid; (CH3-HN-(CH2)3-NH… 
1994
1994
Clinical trials are in progress to evaluate radio- and chemoprotection by the aminothiol 2-[(3-aminopropyl)amino]ethanethiol… 
1994
1994
Reducing agents such as glutathione (GSH), glutathione ester (GSE), and N-acetylcysteine (NAC) have been shown to suppress the… 
1992
1992
Studies were made on the radioprotective and toxic effects of orally administered WR-151327 in male CD2F1 mice. The lowest dose… 
1991
1991
The mutagenic and carcinogenic properties of fission-spectrum neutrons (KERMA-weighted mean energy of 0.85 MeV) from Argonne… 
1990
1990
The systemic effects of the radiation protective agent, S-3-(3-methylaminopropylamino) propylphosphorothioic acid (WR-151327… 
1987
1987
Two phosphorothioate compounds, WR-2721 and WR-151327, were examined for their radioprotective efficacies against the effects of…